89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
| Current price | $6.31 | 52-week high | $16.63 |
| Prev. close | $6.09 | 52-week low | $5.99 |
| Day low | $6.08 | Volume | 1,863,100 |
| Day high | $6.33 | Avg. volume | 950,818 |
| 50-day MA | $8.12 | Dividend yield | N/A |
| 200-day MA | $8.41 | Market Cap | 669.66M |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
| 1-mo | -20.53% |
| 3-mo | -19.21% |
| 6-mo | -34.68% |
| 1-year | -42.22% |
| 3-year | -37.03% |
| 5-year | -77.40% |
| YTD | -19.31% |
| 2024 | -29.99% |
| 2023 | -12.25% |
| 2022 | -2.60% |
| 2021 | -46.37% |
| 2020 | -7.30% |
Loading social stream, please wait...